Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ALKS

Recent news which mentions ALKS

< Previous 1 2 3 4 5 Next >
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Tickers ACHV ACIU AEMD AGEN
Tags OMER Benzinga JAZZ
From Benzinga
7 A-Rated Healthcare Stocks to Buy for the Long Haul
Tickers ALKS BNTX BRKR HSKA
Tags PRTA PFE ALKS
From InvestorPlace
10 Biggest Price Target Changes For Thursday
Tickers ALKS FISV KLAC MCD
Tags KLAC Analyst Ratings SF
From Benzinga
Alkermes plc (ALKS) Q3 2021 Earnings Call Transcript
Tickers ALKS
Tags Market News ALKS
From Motley Fool
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Tickers ABBV ADAP ALIM ALKS
Tags TARO MMSI LLY
From Benzinga
3 Mid-Cap Stocks With Large-Cap Potential
Tickers ALKS OMCL PVH
Tags Market News Stocks to Buy OMCL
From InvestorPlace
2 Supercharged Stocks Near 52-Week Highs Despite the Market Pullback
Tickers ALKS BAC
Tags BAC Market News ALKS
From Motley Fool
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Tickers ABIO ADVM AFIB AGRX
Tags CRXT MBRX TTNP
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Tickers ABBV ADXN AGTC AKYA
Tags SRRK PHAR AZYO
From Benzinga
Benzinga's Bulls And Bears Of The Week: Alibaba, Apple, Nio, PayPal, Verizon And More
Tickers AAPL ALKS ASAN AVGO
Tags Short Ideas Benzinga Trading Ideas
From Benzinga
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
Tickers ALKS
Tags Downgrades ALKS Health Care
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
Tickers ALKS ASMB BLDE CATB
Tags TDC FMCXF ASMB
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tickers ALKS ASMB CTSO EVAX
Tags CTSO INMB EVAX
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Tickers ACIU ADGI ALKS ALPMY
Tags REGN Benzinga RGEN
From Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Tickers ABSI AGEN ALKS AXNX
Tags REGN ESALY Benzinga
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Tickers AGEN ALKS ALZN BLFS
Tags NLTX XNCR INCY
From Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Tickers ABBV AGEN ALKS AVTE
Tags BMY CRBU AGEN
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Tickers ABBV ACN ADBE ADSK
Tags EPAM ZBRA INMD
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Tickers ABVC ACAD ACET ADMA
Tags TLSA ADVM GMTX
From Benzinga
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Tickers ABBV ABSI ACHV ADAG
Tags RMD APTX CHRS
From Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Tickers ABBV ABSI ABVC ACAD
Tags ALKS CTMX ACXP
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Tickers ABVC ACAD ACHL ADGI
Tags PRAX CELU ACAD
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Tickers ACAD ACXP ADGI AKRO
Tags ANIP ATHX Guidance
From Benzinga
Unusual Options Activity Insight: Alkermes
Tickers ALKS
Tags BZI/UOA Market News ALKS
From Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Tickers ABSI ABUS ACAD ACXP
Tags AMRN CNCE NBRV
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Tickers ABSI ACET AERI AKRO
Tags NVTA ORPH AMPH
From Benzinga
Understanding Alkermes's Unusual Options Activity
Tickers ALKS
Tags Benzinga ALKS Movers
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Tickers ABSI ACET ADCT ADVM
Tags XFOR RVVTF NAUT
From Benzinga
Return on Capital Employed Insights for Alkermes
Tickers ALKS
Tags Benzinga ALKS Earnings
From Benzinga
Alkermes Receives FDA Fast Track Status For Mucosal Melanoma Immunotherapy
Tickers ALKS
Tags FDA Health Care News
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.